Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/111169
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kiss, Oliver C. | - |
dc.contributor.author | Scott, Peter J. H. | - |
dc.contributor.author | Behe, Martin | - |
dc.contributor.author | Penuelas, Ivan | - |
dc.contributor.author | Passchier, Jan | - |
dc.contributor.author | Rey, Ana | - |
dc.contributor.author | Patt, Marianne | - |
dc.contributor.author | Aime, Silvio | - |
dc.contributor.author | Jalilian, Amir | - |
dc.contributor.author | Laverman, Peter | - |
dc.contributor.author | Cheng, Zhen | - |
dc.contributor.author | Chauvet, Alain Faivre | - |
dc.contributor.author | Engle, Jonathan | - |
dc.contributor.author | Cleeren, Frederik | - |
dc.contributor.author | Zhu, Hua | - |
dc.contributor.author | Vercouillie, Johnny | - |
dc.contributor.author | van Dam, Michael | - |
dc.contributor.author | Zhang, Ming Rong | - |
dc.contributor.author | Perk, Lars | - |
dc.contributor.author | Guillet, Benjamin | - |
dc.contributor.author | Alves, Francisco | - |
dc.date.accessioned | 2024-01-03T11:48:33Z | - |
dc.date.available | 2024-01-03T11:48:33Z | - |
dc.date.issued | 2023-03-23 | - |
dc.identifier.issn | 2365-421X | - |
dc.identifier.uri | https://hdl.handle.net/10316/111169 | - |
dc.description.abstract | Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This selection of highlights provides commentary on 21different topics selected by each coauthoring Editorial Board member addressinga variety of aspects ranging from novel radiochemistry to first-in-humanapplication of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy arehighlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy andChemistry, demonstrating the progress in the research field, and include newPET-labelling methods for 11C and 18F, the importance ofchoosing the proper chelator for a given radioactive metal ion, implications oftotal body PET on use of radiopharmaceuticals, legislation issues andradionuclide therapy including the emerging role of 161Tb. | pt |
dc.language.iso | eng | pt |
dc.publisher | Springer Nature | pt |
dc.relation | Open Access funding enabled and organized by Projekt DEAL. | pt |
dc.rights | openAccess | pt |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt |
dc.subject | Highlight articles | pt |
dc.subject | Radiochemistry | pt |
dc.subject | Radiopharmacy | pt |
dc.subject | Radiopharmaceutical Sciences | pt |
dc.subject | Nuclear medicine | pt |
dc.subject | Trends in radiopharmaceutical sciences | pt |
dc.title | Highlight selection of radiochemistry and radiopharmacy developments by editorial board | pt |
dc.type | article | pt |
degois.publication.firstPage | 6 | pt |
degois.publication.issue | 1 | pt |
degois.publication.title | EJNMMI Radiopharmacy and Chemistry | pt |
dc.peerreviewed | yes | pt |
dc.identifier.doi | 10.1186/s41181-023-00192-5 | - |
degois.publication.volume | 8 | pt |
dc.date.embargo | 2023-03-23 | * |
dc.identifier.pmid | 36952073 | - |
uc.date.periodoEmbargo | 0 | pt |
dc.identifier.eissn | 2365-421X | - |
item.grantfulltext | open | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.openairetype | article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | Com Texto completo | - |
crisitem.author.orcid | 0000-0001-8054-4267 | - |
Appears in Collections: | I&D ICNAS - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Highlight-selection-of-radiochemistry-and-radiopharmacy-developments-by-editorial-boardEJNMMI-Radiopharmacy-and-Chemistry.pdf | 1.59 MB | Adobe PDF | View/Open |
Page view(s)
35
checked on May 8, 2024
Download(s)
18
checked on May 8, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License